(S)-2-Amino-3-(1H-imidazol-4-yl)propanoic acid hydrochloride hydrate, 95.0%, 25g

(S)-4-Benzyl-2-oxazolidinone>98.0%(GC)5g

Methyl 3-Hydroxyisoxazole-5-carboxylate>98.0%(GC)5g

Silver chloride 99.9999% 5 g

(R)-2-Aminohex-5-enoic acid, 95.0%, 100mg

QUINACRIDONE, 95.0%, 500g

2-(4-Hydroxy-3-methylphenyl)acetic acid, 95.0%, 10g

4,6-BIS((S)-4-ISOPROPYL-4,5-DIHYDROOXAZOL-2-YL)DIBENZO[B,D]FURAN, 98%, 100mg

(S)-2-(5-Chloro-6-methoxynaphthalen-2-yl)propanoic acid, 97%, 1g

methyl 2-hydroxy-4-nitrobenzoate, 95.0%, 1g

(4-((Tetrahydro-2H-pyran-4-yl)oxy)phenyl)methanamine, 95%, 500mg

Plan phase PLPHi 10x/0.25 infinity corrected IOS objective. Working distance 5.00 mm

5-Bromo-2-ethoxypyrimidine, 95.0%, 5g